All In MedTech

Device Trial Radar · NCT06533163

Low-Intensity Oscillatory Magnetic Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme (GBM) - An Exposure-time Escalation Pilot Trial

Last checked: Nov 20, 2026Latest source record: Jun 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Feb 17, 2025

Primary completion

Nov 2027

Study completion Apr 2028

Sponsor

Lead sponsor
BioTex, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Aug 1, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The clinical investigation is a non-randomized, multicenter, open-label, prospective, exposure-time escalation clinical investigation. The clinical investigation is designed to assess the clinical safety and performance of the Oncomagnetic Device.

Conditions

  • Glioblastoma Multiforme

Interventions

  • Oncomagnetic deviceDevice

    OncoMAGNETX has developed a portable wearable noninvasive magnetic device (Oncomagnetic device) for the treatment of GBM.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To assess the safety of the Oncomagnetic device.Time frame: 6 months

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Medical Center Mannheim

    Mannheim, Germany · Recruiting

  • Clinical Center Stuttgart

    Stuttgart, Baden-Wurttemberg, Germany · Recruiting

  • Technical University of Munich

    München, Bavaria, Germany · Recruiting

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.